For following the competition: what moved in each program, several studies read as one move.
- nogapendekin alfa inbakicept
- fropenem
- Allogeneic Invariant Natural Killer T-cells agenT-797
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Community-Acquired Pneumonia to watchlistEvery Monday by email · turn it off any timePro · free during the beta